Diagnostic Microbiology & Infectious Disease
Volume 66, Issue 3 , Pages 292-300 , March 2010

Trends in antibiotic susceptibility of bloodstream pathogens in hospitalized patients in France, 1996 to 2007

  • Jean-Winoc Decousser

      Affiliations

    • Department of Bacteriology and Infection Control, AP-HP, Centre Hospitalier Universitaire Antoine Béclère, 92141 Clamart, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-1-45-37-42-97; fax: +33-1-45-37-48-45.
    • Contributed equally to this article.
    • ,
  • Brigitte Lamy

      Affiliations

    • Department of Biology, Centre Hospitalier du Bassin de Thau, 34200 Sète, France
    • Contributed equally to this article.
    • ,
  • Patrick Pina

      Affiliations

    • Department of Internal Medecin B, Hôpital de Plaisir Grignon, 78310 Plaisir, France
    • ,
  • Pierre Yves Allouch

      Affiliations

    • Department of Infection Control, Centre Hospitalier de Versailles André Mignot, 78157 Le Chesnay, France
    • ,
  • the Collège de Bactériologie Virologie Hygiène study Group (ColBVH)

      Affiliations

    • The ColBVH study group participants are listed in the Acknowledgements.

Received 19 June 2009 ,Accepted 7 October 2009.

References 

  1. Bax R, Bywater R, Cornaglia G, Goosens H, Hunter P, Isham V, et al. Surveillance of antimicrobial resistance—what, how and whither?. Clin. Microbiol. Infect. 2001;7:316–325
  2. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002). Diagn. Microbiol. Infect. Dis. 2004;50:59–69
  3. Cornaglia G, Hryniewicz W, Jarlier V, Kahlmeter G, Mittermayer H, Stratchounski L, et al. European recommendations for antimicrobial resistance surveillance. Clin. Microbiol. Infect. 2004;10:349–383
  4. Dalgaard P. Tabular data; k proportions, test for trend (chapter 7.3). In:  R. Chambers J,  Sheater S,  Eddy W,  Tierney L,  Härdle W editor. Introductory statistics with R. New York: Springer-Verlaag; 2002;p. 133–134
  5. Dalgaard P. ANOVA and Kruskal–Wallis. In:  R. Chambers J,  Sheater S,  Eddy W,  Tierney L,  Härdle W editor. Introductory statistics with R. New York: Springer-Verlaag; 2002;p. 112–127
  6. Decousser JW, Pina P, Picot F, Delalande C, Pangon B, Courvalin P, et al. Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey. J. Antimicrob. Chemother. 2003;51:1213–1222
  7. Decousser JW, Pina P, Viguier F, Picot F, Courvalin P, Allouch PY the ColBVH study group. Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002. Antimicrob. Agents Chemother. 2004;48:3636–3639
  8. EARSS Annual report 2007 . http://www.rivm.nl/earss/Images/EARSS%202007_FINAL_tcm61-55933.pdf2008;(27 November 2008, date last accessed)
  9. Erb A, Stürmer T, Marre R, Brenner H. Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur. J. Clin. Microbiol. Infect. Dis. 2007;26:83–90
  10. Fridkin SK, Hill HA, Volkova NV, Edwards JR, Lawton RM, Gaynes RP, et al. Temporal changes in prevalence of antimicrobial resistance in 23 U.S. Hospitals. Emerg. Infect. Dis. 2002;8:697–701
  11. Galas M, Decousser JW, Breton N, Godard T, Allouch PY, Pina P the ColBVH study group. Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum β-lactamase producing Enterobacteriaceae in France. Antimicrob. Agents Chemother. 2008;52:786–789
  12. Guidelines of the Antimicrobial Committee of the French Society of Microbiology . http://www.sfm.asso.fr/nouv/general.php?pa=22004;(27 November 2008, date last accessed)
  13. Guidelines of the Antimicrobial Committee of the French Society of Microbiology . http://www.sfm.asso.fr/publi/general.php?pa=52007;(27 November 2008, date last accessed)
  14. Guidelines of the National Observatory of the Bacterial Resistance Epidemiology, ONERBA . http://www.onerba.org/rubrique.php3?id_rubrique=152001;(27 November 2008, date last accessed)
  15. Heyn B, Le Moal M, Armand-Lefevre L, Nicolas-Chanoine MH. Multilocus sequence typing (MLST) shows that the “Iberian” clone of oxacillin-resistant Staphylococcus aureus has spread to France and acquired reduced susceptibility to teicoplanin. J. Antimicrob. Chemother. 2002;50:323–329
  16. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control. 2008;36:309–332
  17. Jarlier V, Nicolas M, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 1988;10:867–878
  18. Karlowsky JA, Jones ME, Draghi DC, Thornsberry C, Sahm DF, Volturo GA. Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann. Clin. Microbiol. Antimicrobiol. 2004;10:3–7
  19. Laurent F, Lelièvre H, Cornu M, Vandenesch F, Carret G, Etienne J, et al. Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals. J. Antimicrob. Chemother. 2001;47:277–283
  20. Leibovici L, Vidal L, Paul M. Aminoglycoside drugs in clinical practice: an evidence-based approach. J. Antimicrob. Chemother. 2009;63:246–251
  21. Livermore DM, James D, Reacher M, Graham C, Nichols T, Stephens P, et al. Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990–1999. Emerg. Infect. Dis. 2002;8:473–478
  22. McGregor JC, Rich SE, Harris AD, Prerencevich EN, Osih R, Lodise TP, et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin. Inf. Dis. 2007;45:329–337
  23. Peralta G, Sanchez MB, Garrido JC, Benito D, Cano ME, Martinez-Martinez L, et al. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteremia. J. Antimicrob. Chemother. 2007;60:855–863
  24. Poirel L, Nordmann P. Emergence of plasmid-mediated resistance to fluoroquinolones in Enterobacteriaceae. J. Antimicrob. Chemother. 2005;56:463–469
  25. Reimer LG, Wilson ML, Weinstein MP. Update on detection of bacteremia and fungemia. Clin. Microbiol. Rev. 1997;10:444–465
  26. Robert J, Cambau E, Grenet K, Trystram D, Pean Y, Fievet MH, et al. Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98. Clin. Microbiol. Infect. 2001;7:553–561
  27. Robert J, Bismuth R, Jarlier V. Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983–2002. J. Antimicrob. Chemother. 2006;57:506–510
  28. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Inf. Dis. 2006;6:629–640
  29. Scarsi KK, Feinglass JM, Scheetz MH, Postelnick MJ, Bolon MK, Noskin GA. Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay. Antmicrob. Agents Chemother. 2006;50:3355–3360
  30. Schwaber MJ, De-Medina T, Carmeli Y. Epidemiological interpretation of antibiotic resistance studies—what are we missing?. Nat. Rev. Microbiol. 2004;2:979–983
  31. Shurland S, Zhan M, Bradham BD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to oxacillin-resistant and oxacillin-susceptible Staphylococcus aureus. Infect. Control Hosp. Epidemiol. 2007;28:273–279
  32. Swenson JM, Lonsway D, McAllister S, Thompson A, Jevitt L, Zhu W, et al. Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs. Diagn. Microbiol. Inf. Dis. 2007;58:29–33
  33. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Infect. Dis. 1997;24:584–602
  34. Woodford N. Successful, multiresistant bacterial clones. J. Antimicrob. Chemother. 2008;61:233–234

☆ No funding of any kind has been received for this work.

PII: S0732-8893(09)00417-9

doi: 10.1016/j.diagmicrobio.2009.10.007

Diagnostic Microbiology & Infectious Disease
Volume 66, Issue 3 , Pages 292-300 , March 2010

Article Tools

* Image Usage & Resolution